New patent expiration for Otsuka drug ABILIFY
Annual Drug Patent Expirations for ABILIFY Abilify is a drug marketed by Otsuka and Otsuka Pharm Co Ltd and is […]
Annual Drug Patent Expirations for ABILIFY Abilify is a drug marketed by Otsuka and Otsuka Pharm Co Ltd and is […]
Annual Drug Patent Expirations for NUPLAZID Nuplazid is a drug marketed by Acadia Pharms Inc and is included in two
New patent expiration for Acadia Pharms drug NUPLAZID Read Post »
Annual Drug Patent Expirations for VELCADE Velcade is a drug marketed by Takeda Pharms Usa and is included in one
New patent expiration for Takeda Pharms drug VELCADE Read Post »
Annual Drug Patent Expirations for ADASUVE Adasuve is a drug marketed by Alexza Pharms and is included in one NDA.
New patent expiration for Alexza Pharms drug ADASUVE Read Post »
Annual Drug Patent Expirations for ZETIA Zetia is a drug marketed by Organon and is included in one NDA. There
Annual Drug Patent Expirations for WINLEVI Winlevi is a drug marketed by Sun Pharm and is included in one NDA.
New patent expiration for Sun Pharm drug WINLEVI Read Post »
Annual Drug Patent Expirations for IXEMPRA+KIT Ixempra Kit is a drug marketed by R-pharm Us Llc and is included in
New patent expiration for R-pharm Us drug IXEMPRA KIT Read Post »
Annual Drug Patent Expirations for SPIRIVA Spiriva is a drug marketed by Boehringer Ingelheim and is included in two NDAs.
New patent expiration for Boehringer Ingelheim drug SPIRIVA Read Post »
LEQVIO (inclisiran sodium) Novartis Patent: 10,590,418 Expiration: Jul 19, 2022 See More … For more information on how DrugPatentWatch can
Drug Patent Expirations for the Week of July 17, 2022 Read Post »
Get fresh news and insights, drug patent expirations & more…